Cargando…
Anorectal Mucosal Melanoma: A Case Report and Literature Review
Patient: Female, 81-year-old Final Diagnosis: Anorectal malignant melanoma Symptoms: Hematochezia • obstipation • pain • tenesmuss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology • Oncology OBJECTIVE: Rare disease BACKGROUND: Anorectal mucosal melanoma (AMM) is a rare...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557858/ https://www.ncbi.nlm.nih.gov/pubmed/34699518 http://dx.doi.org/10.12659/AJCR.933032 |
Sumario: | Patient: Female, 81-year-old Final Diagnosis: Anorectal malignant melanoma Symptoms: Hematochezia • obstipation • pain • tenesmuss Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology • Oncology OBJECTIVE: Rare disease BACKGROUND: Anorectal mucosal melanoma (AMM) is a rare and aggressive neoplasm, with a 5-year survival rate of 10%. Due to its rarity and nonspecific symptoms, the diagnosis is often made late. Surgical resection remains the criterion standard for treatment of anorectal melanoma. CASE REPORT: We present the case of an 81-year-old woman presenting with hematochezia, anal secretion, tenesmus, difficulty in defecation, and perianal pain. On physical examination, there was a prolapse of a 5-cm melanocytic nodule in the anal canal, hard on palpation. Biopsy confirmed anorectal melanoma. Staging revealed anal and metastatic disease, with adrenal, lymphatic, and hepatic involvement. As the patient continued to have bleeding, severe pain, and difficulty in defecation, she was submitted to a wide local excision. At 5-month follow-up, the anal lesion had relapsed, and the patient died 10 months after the procedure. CONCLUSIONS: AMM is a rare and extremely aggressive tumor. Symptoms are nonspecific but early diagnosis should be pursued to allow curative treatment. Surgical resection with free margins is the goal of surgical treatment. New therapies are being studied, including immunotherapy, which can improve the dismal prognosis of this rare disease. |
---|